Cellulose
Established medicineAlso known as .ALPHA.-CELLULOSE, ALPHA CELLULOSE, Calcibind, Unifiber.
Recent clinical, regulatory, research and industry developments relating to this drug.
Electrospun membranes based on cellulose nanomaterials for advanced water treatment applications
Fabrication and performance evaluation of TiO2 nanoparticle modified cellulose/PBS biocomposites
Creatine Monohydrate Use and Muscle Stretching in Peripheral Artery Disease
Trainable Bilingual Synaptic Functions in Bio-enabled Synaptic Transistors.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes4
Journals, researchers & institutions
- ACS nano1
- Bioengineered1
- Dai J1
- Feng L1
- Han MJ1
- Tsukruk VV1
- Wang X1
- Wang Z1
- Xie Y1
- Yang X1
- Gachon University1
- Institute of Microbiology Applications1
- School of Materials Science and Engineering1
- Xinjiang Key Laboratory of Special Environmental Microbiology1
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials